From In Vivo Predictive Dissolution to Virtual Bioequivalence: A GastroPlus<sup>®</sup>-Driven Framework for Generic Candesartan Cilexetil Tablets
<b>Background</b>: Candesartan cilexetil, a Biopharmaceutics Classification System (BCS) II prodrug, demonstrates compromised bioavailability attributable to its limited aqueous solubility coupled with P-glycoprotein (P-gp)-mediated efflux and hepatic first-pass metabolism, thereby intro...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/4/562 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|